Community engagement to prevent Type II diabetes in urban Pakistan

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project focuses on adapting, implementing, and evaluating a Participatory Learning and Action (PLA) based intervention aimed at preventing and controlling Type II diabetes in urban Karachi, Pakistan. The intervention is designed to enhance community participation and address the social and behavioral determinants of health. By utilizing evidence-based approaches and best practices, the trial seeks to assess the feasibility and effectiveness of this intervention in an urban context, which has not been previously tested. The study will involve individuals aged 20 and above, including those with normoglycemia, intermediate hyperglycemia, and diabetes, to foster a comprehensive community approach to diabetes management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals aged 20 years and above.
* Participants residing in the randomized clusters of Karachi, Pakistan
* Individuals willing to participate in the study and provide consent.
* Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
* Participants who can attend the scheduled meetings and interventions as per the study protocol.

Exclusion Criteria:

* Individuals below the age of 20 years.
* Individuals unwilling to provide consent for participation.
* Participants with severe health conditions that may hinder their active involvement in the study.
* Individuals with non-compliance with research protocols

Where it's running

• Baqai Institute of Diabetology and Endocrinology (BIDE)
  Karachi, Sindh, Pakistan Recruiting

Study contacts

• Principal investigator: Abdul Basit, Director — Baqai Institute of Diabetes and Endocrinology
• Study coordinator: Abdul Basit, Director
• Email: abdulbasit@bide.edu.pk
• Phone: 922136688897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effect of kidney function on GL0034 exposure in adults with type 2 diabetes

  We will give a single dose of GL0034 to adults with type 2 diabetes who have different levels of kidney function to see if kidney problems change how the body handles the drug.

  Recruiting Phase 1 Sun Pharmaceutical Industries Limited · Miami, Florida and 2 other locations · NCT07385547

• Community participatory learning to prevent and control type 2 diabetes in rural Kabul

  This project will try a community-led participatory learning and action program to prevent and control type 2 diabetes among adults living in rural Kabul.

  Recruiting HealthNet Transcultural Psychosocial Organization · Kabul, Kabul · NCT07350694

• Weekly GL0034 injections for overweight or obese adults with type 2 diabetes

  This study will try weekly GL0034 injections to see if they lower HbA1c and are tolerated in overweight or obese adults with type 2 diabetes.

  Recruiting at 21 sites Phase 2 Sun Pharmaceutical Industries Limited · Little Rock, Arkansas and 20 other locations · NCT07282743

• Community participatory groups to prevent and control Type II diabetes in rural Peshawar and Swabi

  This project will try a community group-based Participatory Learning and Action program to help prevent and control Type II diabetes among adults living in rural Peshawar and Swabi, Pakistan.

  Recruiting Khyber Medical University Peshawar · Peshawar, KPK · NCT06561126

• Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes

  This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.

  Recruiting at 2 sites Phase 4 Getz Pharma · Kabul, Afghanistan and 5 other locations · NCT05164263

• Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing

  A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jang XI · NCT07881588

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.